CMT Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-60,100
Closed -$14.6M 179
2017
Q2
$14.6M Sell
60,100
-22,200
-27% -$5.22M 0.97% 33
2017
Q1
$19.7M Sell
82,300
-60,000
-42% -$14M 1.66% 21
2016
Q4
$29.8M Buy
142,300
+54,100
+61% +$11.2M 1.4% 23
2016
Q3
$20.3M Sell
88,200
-66,700
-43% -$16.3M 0.93% 38
2016
Q2
$35.8M Buy
154,900
+59,400
+62% +$13.7M 1.8% 14
2016
Q1
$25.6M Buy
95,500
+80,000
+516% +$22.9M 1.72% 13
2015
Q4
$4.84M Buy
+15,500
New +$4.61M 0.25% 92

Other funds holding AGN

CMT Asset Management's AGN Position: Q1 2017 in Review

CMT Asset Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 7,985 shares — an estimated $1.86M sold.

CMT Asset Management first reported a position in AGN in Q4 2015 and held it in 2 quarters. The position peaked at $3.34M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • CMT Asset Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • CMT Asset Management sold 7,985 Allergan plc shares in Q1 2017, an estimated $1.86M.
  • CMT Asset Management first reported a position in Allergan plc in Q4 2015 and held it in 2 quarters.
  • CMT Asset Management's Allergan plc position peaked at $3.34M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on CMT Asset Management's 13F filing for Q1 2017, filed 15 May 2017.